Steve Gentleman

11.2k citations

95 papers · 8.0k indexed · 4 hit papers · h-index 43

Impact in

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
- Neurological disorders and treatments
- Neurological diseases and metabolism
Biological Psychiatry top 1%

Papers in

Neurology 29
- Parkinson's Disease Mechanisms and Treatments 30
- Neuroinflammation and Neurodegeneration Mechanisms 16
- Neurological disorders and treatments 11
- Neurological diseases and metabolism 10
- Traumatic Brain Injury and Neurovascular Disturbances 10
Biological Psychiatry 5

Co-authors: R. K. B. Pearce Magdalena Sastre G.W. Roberts David I. Graham W. Sue T. Griffin Michail E. Kalaitzakis Alan King Lun Liu Lefkos Middleton
Journals: Neuropathology and Applied Neurobiology (11 papers)Acta Neuropathologica (10 papers)Acta Neuropathologica Communications (7 papers)Proceedings of the National Academy of Sciences (3 papers)Brain (3 papers)
Partner nations: United Kingdom United States Hong Kong

In The Last Decade

Steve Gentleman

93 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism 2015 · 542 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Proceedings of the National Academy of Sciences
2011 Annals of Neurology
2011 Brain
1998 Brain Pathology

Peers

Countries citing papers authored by Steve Gentleman

Since Specialization

Citations

This map shows the geographic impact of Steve Gentleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Gentleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Gentleman more than expected).

Fields of papers citing papers by Steve Gentleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Gentleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Gentleman. The network helps show where Steve Gentleman may publish in the future.

Co-authors

The 25 scholars most cited alongside Steve Gentleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Gentleman Line = papers co-authored together Steve Gentleman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reduced DJ-1-F1Fo ATP synthase association correlates with midbrain dopaminergic neuron vulnerability in idiopathic Parkinson’s disease Science Advances ·Amina Abulimiti, Haesoo Bae, Amar M. Ali, Shanmuganathan Balakrishnan, M Tsujishita, Djordje Gverić, Travis S. Tierney, Elizabeth A. Jonas, Peter J. Smith, Steve Gentleman, Kambiz N. Alavian	2025	1
2	Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects Journal of Alzheimer s Disease ·Fangda Leng, Rainer Hinz, Steve Gentleman, Melanie Dani, David J. Brooks, Paul Edison	2024	1
3	Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue Acta Neuropathologica Communications ·C. Tauber, Sigrid C. Schwarz, Thomas W. Rösler, Thomas Arzberger, Steve Gentleman, Otto Windl, Mandy Krumbiegel, André Reis, Viktoria Ruf, Jochen Herms, Günter U. Höglinger	2023	9
4	Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease npj Parkinson s Disease ·Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi	2023	41
5	Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains Brain Communications ·Valerija Dobričić, Marcel Schilling, I Farkas, Djordje Gverić, Olena Ohlei, Jessica Schulz, Lefkos Middleton, Steve Gentleman, Laura Parkkinen, Lars Bertram, Christina M. Lill	2022	13
6	Neuroinflammation is independently associated with brain network dysfunction in Alzheimer’s disease Molecular Psychiatry ·Fangda Leng, Rainer Hinz, Steve Gentleman, Adam Hampshire, Melanie Dani, David J. Brooks, Paul Edison	2022	66
7	Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology Neuropathology and Applied Neurobiology ·Eduardo De Pablo‐Fernández, Robert J. Courtney, Alice Rockliffe, Steve Gentleman, Janice L. Holton, Thomas T. Warner	2021	22
8	Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease Journal of Neural Transmission ·Antonio Martín‐Bastida, Bension S. Tilley, Sukhvinder S. Bansal, Steve Gentleman, David T. Dexter, Roberta J. Ward	2020	37
9	A novel method to visualise the three‐dimensional organisation of the human cerebral cortical vasculature Journal of Anatomy ·Charlotte H. Harrison, George R. Buckland, SP Brooks, David A. Johnston, David S. Chatelet, Alan King Lun Liu, Steve Gentleman, Delphine Boche, James A. R. Nicoll	2018	9
10	Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects European Journal of Nuclear Medicine and Molecular Imaging ·Zhen Fan, Melanie Dani, Grazia Daniela Femminella, Melanie Wood, Valeria Calsolaro, Mattia Veronese, Federico Turkheimer, Steve Gentleman, David J. Brooks, Rainer Hinz, Paul Edison	2018	22
11	MSA prions exhibit remarkable stability and resistance to inactivation Acta Neuropathologica ·Amanda L. Woerman, Sabeen A. Kazmi, Smita S. Patel, Yevgeniy Freyman, Abby Oehler, Atsushi Aoyagi, Daniel A. Mordes, Glenda M. Halliday, Lefkos Middleton, Steve Gentleman, Steven H. Olson, Stanley B. Prusiner	2017	73
12	Amyloid pathology and axonal injury after brain trauma Neurology ·Gregory Scott, Anil Ramlackhansingh, Paul Edison, Peter J. Hellyer, James H. Cole, Mattia Veronese, Robert Leech, Richard Greenwood, Federico Turkheimer, Steve Gentleman, Rolf A. Heckemann, Paul M. Matthews, David J. Brooks, David Sharp	2016	110
13	Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism Proceedings of the National Academy of Sciences ·Stanley B. Prusiner, Amanda L. Woerman, Daniel A. Mordes, Joel C. Watts, Ryan Rampersaud, David B. Berry, Smita S. Patel, Abby Oehler, Jennifer K. Lowe, Stephanie N. Kravitz, Daniel H. Geschwind, David V. Glidden, Glenda M. Halliday, Lefkos Middleton, Steve Gentleman, Lea T. Grinberg, Kurt Giles Hit paper breakdown →	2015	542
14	Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease Acta Neuropathologica ·Alan King Lun Liu, Raymond Chuen‐Chung Chang, R. K. B. Pearce, Steve Gentleman	2015	267
15	Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein Molecular and Cellular Biology ·Callum Parr, Raffaela Carzaniga, Steve Gentleman, Fred Van Leuven, Jochen Walter, Magdalena Sastre	2012	140
16	Trials and tribulations of using β-amyloid precursor protein immunohistochemistry to evaluate traumatic brain injury in adults Forensic Science International ·David I. Graham, Colin Smith, R. Ross Reichard, Pascale D. Leclercq, Steve Gentleman	2003	50
17	Developmental Regulation and Possible Alternative Cleavage of Presenilin 1 in the Rat Retina Molecular and Cellular Neuroscience ·Laura G. Bresciani, Dominic M. Walsh, Steve Gentleman, L.S. Jen	2002	6
18	Effects of bFGF and TGFβ on the expression of amyloid precursor and B-cell lymphoma protooncogene proteins in the rat retina Neuroreport ·S T. Chen, Angela Jen, Steve Gentleman, L.S. Jen	1999	7
19	Markers of axonal injury in post mortem human brain Acta Neuropathologica ·F. E. Sherriff, Leslie Bridges, Steve Gentleman, S. Sivaloganathan, Stephen M. Wilson	1994	189
20	Differential pattern of β‐amyloid protein deposition within cortical sulci and gyri in Alzheimer's disease Neuropathology and Applied Neurobiology ·Joanne Clinton, G.W. Roberts, Steve Gentleman, M.C. Royston	1993	16

About Steve Gentleman

Steve Gentleman is a scholar working on Neurology, Neurology, Biological Psychiatry, Physiology and Cellular and Molecular Neuroscience, having authored 95 papers that have together received 8.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (37 papers), Parkinson's Disease Mechanisms and Treatments (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers), S100 Proteins and Annexins (13 papers), Neuroscience and Neuropharmacology Research (13 papers), Neurological disorders and treatments (11 papers), Neurological diseases and metabolism (10 papers) and Traumatic Brain Injury and Neurovascular Disturbances (10 papers). The work is most often cited by research in Neurology (2.4k citations), Neurology (3.6k citations), Biological Psychiatry (296 citations), Developmental Neuroscience (444 citations) and Physiology (2.3k citations). Steve Gentleman has collaborated with scholars based in United Kingdom, United States and Hong Kong. Frequent co-authors include R. K. B. Pearce, Magdalena Sastre, G.W. Roberts, David I. Graham, W. Sue T. Griffin, Michail E. Kalaitzakis, Alan King Lun Liu, Lefkos Middleton, David J. Brooks and M.C. Royston. Their work appears in journals such as Neuropathology and Applied Neurobiology, Acta Neuropathologica, Acta Neuropathologica Communications, Proceedings of the National Academy of Sciences and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact